Transcatheter Intervention for Management of Tricuspid Regurgitation Using TriClip

Anmol Sharedalal,Alexandra Zois,Parija Sharedalal,William H. Frishman,Wilbert S. Aronow
DOI: https://doi.org/10.1097/crd.0000000000000740
2024-06-27
Cardiology in Review
Abstract:Severe tricuspid regurgitation (TR) is an underrated, common pathology that affects over 70 million individuals worldwide. Traditionally, TR has been managed with diuretic therapies without any significant mortality benefit. The underlying cause of TR can be primary, coming from structural issues with tricuspid valve and more commonly secondary, arising from conditions affecting the right ventricle or the pulmonary circulation. Management of TR has seen few improvements until recently. Traditionally, valve replacement and surgical repair were the therapeutic options available. Tricuspid valve is a complex cardiac structure with many technical challenges for surgical intervention. Transcatheter valve interventions have proven to be safe and effective novel therapeutic options for severe TR, which reduce the severity of TR with associated improvement in quality of life. In this review, we will provide an overview of the management of severe TR utilizing transcatheter edge-to-edge repair with the TriClip device (Abbott, Santa Clara, CA).
cardiac & cardiovascular systems
What problem does this paper attempt to address?